Ascentage Pharma Group International (AAPG) Stock Chart & Stock Price History $36.76 +0.56 (+1.55%) As of 07/15/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsFDA EventsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Ascentage Pharma Group International Stock Price Performance The Ascentage Pharma Group International (AAPG) stock chart highlights key performance trends across multiple timeframes. In the past month, the stock has increased 14.41%, reflecting recent market activity. As of the latest close, Ascentage Pharma Group International traded at $36.76 with a market cap of $3.20 billion and volume of 12,546 shares. Receive AAPG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ascentage Pharma Group International and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.87%1 Month Performance+14.41%3 Month Performance+94.81% AAPG Stock Chart for Wednesday, July, 16, 2025 AAPG Chart by TradingView Ascentage Pharma Group International Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$36.20$36.76+1.55%$38.22$36.7612,546 shs$3.20 billion07/14/2025$38.24$36.20-5.33%$37.05$36.0817,211 shs$3.15 billion07/11/2025$40.74$38.24-6.14%$38.95$38.156,315 shs$3.33 billion07/10/2025$41.87$40.74-2.70%$42.47$40.4717,472 shs$3.55 billion07/09/2025$41.35$41.87+1.26%$42.94$41.055,040 shs$3.65 billion07/08/2025$42.04$41.35-1.64%$41.53$41.0611,910 shs$3.60 billion07/07/2025$42.85$42.04-1.89%$42.52$41.616,047 shs$3.66 billion07/04/2025$42.85$42.85$43.58$41.5022,456 shs$3.73 billion07/03/2025$39.85$42.85+7.53%$43.58$41.5022,456 shs$3.73 billion07/02/2025$38.99$39.85+2.21%$39.85$38.445,604 shs$3.47 billion Get the Latest News and Ratings for AAPG and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ascentage Pharma Group International and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$39.38$38.99-0.99%$39.76$38.685,597 shs$3.40 billion06/30/2025$39.60$39.38-0.56%$39.78$38.836,788 shs$3.43 billion06/27/2025$40.81$39.60-2.96%$39.99$37.006,734 shs$3.45 billion06/26/2025$39.99$40.81+2.05%$40.81$38.0014,448 shs$3.56 billion06/25/2025$39.70$39.99+0.73%$40.19$38.6019,479 shs$3.48 billion06/24/2025$37.15$39.70+6.86%$40.39$38.7025,539 shs$3.46 billion06/23/2025$37.38$37.15-0.62%$37.36$35.979,065 shs$3.24 billion06/20/2025$35.88$37.38+4.18%$37.95$36.4025,208 shs$3.26 billion06/19/2025$35.88$35.88$36.14$34.7424,725 shs$3.13 billion06/18/2025$31.64$35.88+13.40%$36.14$34.7424,725 shs$3.13 billion06/17/2025$32.13$31.64-1.53%$32.00$31.084,195 shs$2.76 billion06/16/2025$31.51$32.13+1.97%$32.33$31.355,909 shs$2.80 billion Related Companies ITCI Stock Price Chart GMAB Stock Price Chart MRNA Stock Price Chart RDY Stock Price Chart VTRS Stock Price Chart QGEN Stock Price Chart ASND Stock Price Chart VRNA Stock Price Chart BBIO Stock Price Chart BPMC Stock Price Chart Receive AAPG Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ascentage Pharma Group International and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:AAPG) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCentral Banks Are Hoarding Gold – Should You?The AI boom isn’t just transforming technology—it’s redefining global power, increasing government debt, and u...Lear Capital | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | SponsoredMajor Rollout of Social Security X?To All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredWhich Gold Miner Trades at 30% of NAV? The One Buffett WantsSome of the world’s best gold developers are trading at just 30% of NAV — like buying a dollar for 30 cents. ...Golden Portfolio | SponsoredWhy Elon is funding the “Quantum Power Grid”Elon knows the future isn’t about smarter AI — it’s about powering it. And this new technology is quietly b...True Market Insiders | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ascentage Pharma Group International - Unsponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share Ascentage Pharma Group International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
